The function of the GTPase Rac1, a molecular switch transducing intracellular signals from growth factors, in differentiation of a specific cell type during early embryogenesis has not been investigated. To address the question, we used ES cells differentiated into cardiomyocytes, a model which faithfully recapitulates early stages of cardiogenesis. Overexpression in ES cells of a constitutively active Rac (RacV12) but not of an active mutant (RacL61D38) 
INTRODUCTION
The ras superfamily of monomeric GTPases include the Rho, Ran, Rab, Rad/Gem, Arf and the Ras families. These GTPases exert profound effects upon cell function and structure (Van Aelst and D'Souza-Schorey, 1997) . Ran or Rab proteins mediate two very specific cellular events, i.e., nucleocytoplasmic shuttling and vesicular transport, respectively. In contrast, the Rho GTPases affect various cellular functions (Bishop and Hall, 2000) including cytoskeleton rearrangement, cell motility, cell growth or cytokinesis (Takai et al., 2001 ). Importantly, they play a role in embryogenesis (Settleman, 2001 ).
The Rho GTPases work as molecular switches to transduce intracellular signals from growth factors or G protein coupled receptors. The role of these GTPases in cardiac cell differentiation and heart function is not well understood. Recent in vitro studies indicate that RhoA and Rac may mediate the hypertrophic responses of agonists binding to seven transmembrane domains receptors (Sah et al., 2000) .
However, increased expression of RhoA in heart leads to a conduction abnormality and in turn to ventricular failure with no sign of hypertrophy (Sah et al., 1999) .
Transgenic mice overexpressing a dominant positive mutant of Rac1 developed cardiac hypertrophy within weeks after birth, and this was associated with an alteration of focal adhesions. These animals featured a dilated cardiomyopathy accompanied with a decreased myofibril density and changes in cell adhesion structures (Sussman et al., 2000) . Wei et al, reported a crucial role of RhoGTPases in foetal cardiac cell proliferation in mice expressing RhoGDI (Wei et al., 2002) .
Rho GTPases mediate signals from growth factors such as TGFβ (Mucsi et al., 1996) (Atfi et al., 1997) , a key cardiogenic factor. Yet, their specific role in early events of cardiac cell proliferation and differentiation is not known. Little information as to this issue can be obtained from transgenic mice, since the α-MHC promoter most often used to generate these genetically modified animals is mainly turned on at birth, at a time when myocytes became postmitotic cells. Similarly, RhoGDI overexpressing mice did not allow determination of the role of a specific Rho GTPase.
In this study, we investigated the role of Rac in mouse embryonic stem (ES) cell differentiation as a model of cardiac cell differentiation, which recapitulates the early stages of the complex program of mouse embryogenesis (Leahy et al., 1999) . E02-09-0562 R1 4 We show that Rac effects depend upon the stage of cell differentiation and that Rac
GTPase activity inhibits cardiac cell differentiation at very early stages and then later promotes proliferation and myofibrillogenesis of cardiomyocytes E02-09-0562 R1 5
MATERIALS AND METHODS

Plasmid construction, ES cell clone
cDNAs encoding the GTPases RhoAV14, RhoGV12 and RacV12 were subcloned in a retroviral vector. G418-resistant GP+E-86 clones expressing constitutively activated mutants of Rho GTPases were grown to collect retrovirus (Roux et al., 1997) . ES cells were infected with retrovirus overnight. cDNAs encoding RacV12, RacN17, RacF28 were also subcloned in a bicistronic vector (pIRES2GFP) in which the CMV promoter sequence was excised and replaced by the 250 bp sequence of MLC2v promoter (Meyer et al., 2000) . The linearized plasmid DNAs were electroporated into CGR8 ES cells according to standard protocol (Meyer et al., 2000) . The ES clones were propagated in the presence of LIF-conditioned medium obtained from LIF-D cells and selected for ten days by incubation with G418
(250µg/ml) and further screened by PCR. Individual ES cell clones were screened by PCR for expression of GTPases. At least three independent cell clones were used for each GTPase.
cDNA encoding MLC2v was subcloned into pEGFP-N1 using the restriction sites Sal/BamH1 to generate the expression vector encoding MLC2v-GFP fusion protein.
Rac mutation
A PCR-driven amplification approach was used to generate a point mutation in the cDNA encoding RacL61 (Freeman et al., 1996) to obtain a constitutively active mutant, which lost the ability to activate the membrane NADPH oxidase (Nisimoto et al., 1997) . Aspartate at position 38 was replaced by a lysine. A first PCR fragment of 500 bp was amplified using a forward primer including the mutation (5'-GCTGAAGGAGGAGAAGCTGACT-3') and a reverse primer in the 3' region of RacL61 (5'-GCTCGAGCTACAACAGGCATTTTC-3') including a BamH1 restriction site. The PCR fragment was used as a reverse primer in the second PCR round together with a forward primer in the 5' region of the vector (5'-GGAATTCATGCATGCAGGCCATCAAGTG-3') including an EcoRI site.
Mutation was checked by sequencing the cDNA encoding RacL61D38 which was subcloned into pIRES2-EGFP vector (Clontech) using the BamH1 and EcoRI sites.
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ES cell differentiation
ES cells (CGR8) were propagated in BHK21 medium supplemented with pyruvate, non essential amino acids, mercaptoethanol, 7.5% fetal calf serum and LIF conditioned medium obtained from pre-confluent LIF-D cells stably transfected with a plasmid encoding LIF. The cells were trypsinized and replated every two days.
Differentiation was carried out using the hanging drop method. Briefly, embryoid bodies (EBs) were formed in hanging drops of differentiation medium (BHK21 medium supplemented with pyruvate, non-essential amino acids, mercaptoethanol and 20% fetal calf serum without LIF) for two days (D0-2). Then, the EBs were incubated for three days in suspension (D2-5) and for at least seven days on gelatin coated dishes or laminin coated glass coverslips (D6-12) (Meyer et al., 2000) .
Isolation of ES-derived cardiomyocytes
To isolate ES-derived cardiomyocytes, embryoid bodies were detached from dishes at day 10 by incubation for one min with 0.05% trypsin at 37°C (in phosphatebuffered saline, 1 mM EDTA). Embryoid bodies were dissociated with 1 mg/ml collagenase (CLSII, Worthington) and 0.25 mg/ml pancreatin in a buffer containing (in mmol/L) NaCl 117, HEPES 20, NaH 2 PO 4 1.2, KCl 5.4, MgSO 4 1, glucose 5 (adjusted to pH 7.35). Cells were separated by centrifugation through a discontinuous 2-layers Percoll gradient. Stem cell-derived cardiomyocytes were present at the interface between the two layers. They were collected and immediately plated on gelatin-coated glass dishes
Transfection of neonatal rat and ES-derived cardiomyocytes
Ventricular myocytes were isolated from 2-3 days old rats and plated for 24hrs
in DMEM/M199 medium. Neonatal rat cardiomyocytes were then co-transfected with plasmids encoding RacL61D38 mutant and the red fluorescent protein (pCMVDsRed, Clontech) using Effectene (Quiagen, France) as previously described (Bony et al., 2001 ). The same transfection protocol was used to transfect plasmids encoding the GTPases or MLC2vGFP in ES-derived cardiomyocytes.
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Measurement of reactive oxygen species in neonatal rat cardiomyocytes
To monitor ROS production, myocytes were loaded for 20 min with 10 µM 2', 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (DCHF) (Molecular Probes, Leiden, The Netherland). After washing, cells then transferred to the stage of an inverted epifluorescence LEICA DMRA microscope equipped with a 63X objective. Transfected cells were selected by RFP expression using a set of rhodamine filter (excitation 545±10, emission 625±15 nm) and fluorescence of DCHF was measured using a set of FITC filters (excitation 485±10 and emission at 535±20 nm) using a MicroMax 1300 Y/HS CCD camera (Princeton, USA) driven by Metamorph (Universal Imaging Corporation,USA).
Mouse Embryos
Mouse embryos were collected from mice at days 6, 9, and 11 post-coïtum.
RNA was isolated from total heart, ventricle or atria using a standard protocol (Chomczynski and Sacchi, 1987) . After reverse transcription, encoding sequence of Rac1 was amplified from the cDNA using a specific set of primers (sense : 5'-TGGGAGACGGAGCTGTTGGTAAAACC-3' and antisense 5'-ACTTGGCATCAA ATGCG -3').
Cell immunofluorescence microscopy
EBs (D12-14) were fixed in 3% paraformaldehyde for 30 min and permeabilized for 30 min with 1% Triton X100. The ES-derived isolated cardiomyocytes were fixed in 3 % paraformaldehyde for 10 min and permeabilized for 10 min with 0.5 % Triton X100. Immunostaining was performed as previously described with polyclonal anti-MLC2a and anti-MLC2v antibodies (Meyer et al., 2000) . Monoclonal mouse anti-actinin, monoclonal rat anti-Ki67 or polyclonal anti-MEF2C antibodies were purchased from Sigma (France), Dako (France), and Cell Signalling (U.SA), respectively. Industries) and visualized using Imaris (Bitplane, Switzerland).Beating activity was monitored by videomicroscopy using the stream acquisition mode, and beating areas were measured using the region measurement option of Metamorph. The latter were normalised to the total mesoderm area.
RT-PCR and real time quantitative PCR
Total RNA was prepared from 10 EBs after cell lysis in guanidinium thiocyanatecontaining buffer using a modified phenol chloroform extraction (Chomczynski and Sacchi, 1987) . After reverse transcription, 100 to 300 ng cDNA was used for semiquantitative PCR to stay within the linear range of amplification. PCR was carried out using a set of gene specific primers as previously described (Meyer et al., 2000) . Rho
A and RhoG were amplified for 36 cycles using the following primers, RhoA: forward TGGAGCTTGTGGTAAGACATGC and reverse AGAATCCCCCAAGGAA CTCG;
RhoG: forward GTGCTTAACCCAACACC and reverse CACATCTTTC TTCTCA.
Rac 1 was amplified using the primers described in the embryo section. Tubulin, βMHC, GATA4 and MLC2v cDNAs were amplified for 30 cycles. Nkx2.5, and heating the product at 20°C/s to 95°C, then cooling it at 20°C/s to 70°C. The reaction was maintained at 70°C for 20 s followed by slow heating at 0.3°C/s to 95°C. Melting curves were used to determine the specificity of PCR products, and they were further confirmed by gel electrophoresis.
Rac GTPase activity and Western blot analysis
Rac activity was measured with an assay activity kit (Upstate Biotechnology) using a GST-conjugated PAK-1 protein binding domain according to manufacturer instructions. Proteins were extracted from embryoid bodies in NET (NaCl, EDTA, Tris) buffer containing 1% NP40 (Bony et al., 2001 ). Proteins were assayed using the bradford reagent and a same amount per well was run in 12 % SDS-PAGE and transferred to a nitrocellulose membrane as previously described. Blots were probed with a polyclonal anti-Rac (Santa Cruz), anti-gp91phox, or anti-p67phox (De Leo et al., 1996) and polyclonal anti α-tubulin as indicated, and a secondary peroxidase conjugated antibody. Immunoreactive proteins were revealed by ECL (Bony et al., 2001 ).
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RESULTS
Early expression of Rac1 in stem cells and mouse embryos
During mouse embryogenesis, Rac1 mRNA was weakly expressed in embryos at E6, and the protein was barely detectable in western blots. Expression was enhanced and Rac1 mRNA and protein reached their maximal level at E9 and E11, respectively.
Furthermore, Rac1 was expressed in heart both in atria and ventricles, with a higher expression in ventricles (Fig. 1AB) . We further investigated expression of Rac1 in vitro in ES-derived embryoid bodies. Rac1 mRNA was found as early as in undifferentiated ES cells and its expression remained unchanged in embryoid bodies (EB) up to day 12 (Fig. 1C) . Rac activity was however not detected in undifferentiated ES cells.
Constitutively active Rac1 impairs cardiac differentiation of ES cells
To determine the role of the Rac GTPase in cardiac cell differentiation of ES cells, we generated an ES cell line expressing a constitutively active or a dominant negative mutant of Rac (RacV12, or RacN17, respectively). In RacV12 embryoid bodies, Rac activity was increased by 5±0.8 fold (n=3), while Rac activity was abolished in RacN17 cell line (our unpublished results). The RacV12 cell line was then tested for its ability to differentiate into functional cardiomyocytes. Since the RacV12 expression vector contained an ubiquitous promoter, Rac was broadly expressed after differentiation in most cells of the three layers (i.e., ectoderm, mesoderm, endoderm) of the EB. The cardiac phenotype of embryoid bodies (i.e. structure and function of ES-derived cardiomyocytes) expressing RacV12 was compared to that of EBs overexpressing other constitutively active mutants of RhoGTPases, namely RhoAV14
and RhoGV12 (Fig. 2 , inset ).
Beating activity of embryoid bodies generated from RhoAV14, RhoGV12 ES cells showed that these cells differentiated into cardiac cells as well as MLCECFP ES cells, a control cell line expressing ECFP under the control of the ventricular myosin light chain 2 (MLC2v) promoter (Meyer et al., 2000) (Fig. 2) . In contrast, although RacV12 EBs displayed the three layers structure (our unpublished results), they lost their ability to beat, indicating a potential defect in cardiac differentiation and/or excitation-contraction coupling of ES-derived cardiomyocytes.
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Mechanism underlying RacV12 induced impairment of cardiac cell differentiation
To understand the mechanism of inhibition of beating activity in RacV12 EBs, mRNAs encoding cardiac transcription factors were amplified by PCR after reverse transcription of RNA extracted from EBs at day 5. Expression of Nkx2.5 or GATA4
mRNA was not different in RacV12 EBs than in EBs expressing RhoGV12 or ECFP.
In contrast, MEF2C expression was dramatically decreased in RacV12 EBs (Fig3A).
To confirm this result, real time quantitative PCR was performed. This more quantitative approach revealed that MEF2c mRNA expression was eight times lower in RacV12 EBs, as compared to controls (Fig 3B) . Furthermore, we were also not able to detect MEF2C protein in RacV12 EBs using western blot or immunofluorescence (our unpublished results).
Expression of genes encoding constitutive contractile proteins such as MLC2v
and myosin heavy chain (β−MHC) was also determined in EBs expressing constitutively active Rho GTPases. Figure 4 shows that in RacV12 EBs but not in any Fig. 5B ).
Figure 5B shows that beating activity of RacV12/MEF2C EBs was restored, and it E02-09-0562 R1 12 was comparable to control EBs. MLC2v expression and sarcomerogenesis were also both restored in RacV12/MEF2C EBs (Fig.5CD ).
Reactive oxygen species trigger downregulation of MEF2C expression and accounts for the phenotype of RacV12 ES-derived cardiomyocytes.
We next addressed the mechanism of downregulation of the MEF2C gene in RacV12
EBs. One important and specific effector of Rac is a membrane-associated NADPH oxydase, which generates reactive oxygen species (ROS) (Babior, 1999) . ROS are known to repress the activity of promoters for several genes including myoD and α-actin (Morel and Barouki, 1999) . Thus, we evaluated the role of ROS in cardiac differentiation of ES cells by incubating embryoid bodies with 100 nM H 2 0 2 from day 0 to 7. For these experiments, we utilized cells expressing ECFP under control of the α-actin promoter (Behfar et al., 2002) to track the cardiomyocytes at an early stage of differentiation. Figure 6A shows that clusters of ECFP expressing cells were detected as early as day 5 in control EBs, while no fluorescence could be observed in EBs treated with H 2 0 2 . Furthermore, H 2 0 2 dramatically prevented beating activity of EBs (Fig. 6B ) and decreased MEF2C expression (Fig 6C) . This is reminiscent of the interestingly, the beating activity of EBs and the number of cardiomyocytes with sarcomeric actinin within the EBs was increased (Fig 7BD) compared to RacV12 embryoid bodies (Fig. 4) . As an alternative approach, we reasoned that if Rac-induced activation of NADPH oxydase impaired cardiac cell differentiation, a scavenger of ROS should relieve this effect. Thus, we added in the differentiation medium of RacV12 EBs 1000 U /ml catalase. Added at day 5, catalase partially rescued beating activity of RacV12 EBs. Added as early as day 2, the ROS scavenger fully restored beating activity of EBs (Fig. 7C) (Fig. 7D ).
Inhibition of endogenous Rac impaired beating activity of embryoid bodies.
We then allowed an ES cell clone expressing a dominant negative mutant of rac (RacN17) to differentiate. Inhibition of Rac as early as in ES cells did not affect the process of cardiac differentiation as revealed by normal expression of the transcription factors Nkx2.5 and MEF2C, or of the constitutive cardiac genes, βMHC or MLC2v (Fig. 8A ). However spontaneous activity of EBs was severely impaired (Fig. 8B ). Actinin staining of EBs revealed the presence of cardiomyocytes (Fig. 8C) but a poor myofibrillogenesis. Indeed sarcomeric units of ES-derived cardiomyocytes were not fully organised (Fig 8D) .
Late and cardiac-restricted expression of RacV12 improves cardioblasts proliferation and myofibrillogenesis
To further investigate the specific role of Rac in cardiac differentiation, we generated a DNA vector including the MLC2v promoter to exclusively express a dominant negative (RacN17), a fast cycling (RacF28) (Lin et al., 1999) , or a dominant active (RacV12) Rac mutant in ES-derived ventricular cells. Furthermore, this approach allowed us to bypass early expression of RacV12. Indeed, when RacV12 was expressed under the control of MLC2v promoter, the GTPase was overexpressed only in ES-derived ventricular cardiomyocytes from days 5-7 of differentiation when the MLC2v promoter was turned on as visualized by GFP expression in beating cells E02-09-0562 R1 14 (Meyer et al., 2000) . Cardiac differentiation of these cells was greatly improved within the EBs, as shown by the beating activity of EBs (Fig. 9A) Fig. 9C ) as previously found in CMVRacN17 ES-derived cardiomyocytes (Fig. 8D) .
Next, we isolated ES-derived cardiomyocytes from MLCRacV12 or MLCECFP embryoid bodies and plated them in culture. Using both an antibody raised against Ki67, a proliferative marker expressed in any stage of cell cycle of mitotic cells but G0 (Scholzen and Gerdes, 2000) , and BrdU revealed that ES-derived cardiomyocytes expressing RacV12 were still proliferating at day 3 post-isolation, while most of the cardiomyocytes expressing ECFP exited the cell cycle (Fig. 9D) . (Harvey, 1999) , resulted in a poor expression of MLC2v, which compromised the organization of myofibrils. This would be expected, based on the key role of this protein in the formation of sarcomeres (Chen et al., 1998) .
DISCUSSION
Restoration of both sarcomerogenesis and beating activity by overexpression of MEF2C in RacV12 ES-derived cardiomyocytes demonstrates that lack of expression of the transcription factor is at the origin of the defect in cardiac cell differentiation of RacV12 ES cells.
Searching for the mechanism underlying the impaired expression of MEF2C
in RacV12ES cells, we reasoned that such a mechanism should be specific of RacV12 since MEF2C was expressed to the same extent in ES-derived cardiomyocytes expressing constitutively active mutants of other RhoGTPases (i.e, RhoG, RhoA) as in control MLCECFP cells. Therefore, we looked for a Rac specific effector. The membrane NADPH oxidase is a major and specific Rac1/Rac2 effector enzyme (Archer and Bar-Sagi, 2002; Babior, 1999 highly expressed in embryonic tissues, including the heart, and in early differentiation stages of ES-derived embryoid bodies (Cheng et al., 2001 ) (Sauer et al., 2000), Fig6D) . Since ROS repress expression of numerous cardiac genes (Morel and Barouki, 1999) , we evaluated the involvement of ROS in the repression of MEF2C expression by studying the propensity of ES cells expressing a constitutively activated mutant of Rac (RacL61D38), which lost the ability to bind p67phox and in turn to E02-09-0562 R1 16 activate the NADPH oxidase (Nisimoto et al., 1997) , to differentiate into cardiac cells (Fig 7) . Such cells expressed normal levels of MEF2C, featured regular sarcomeres and thus differentiated normally into functional beating cardiac cells. Furthermore, day to day addition of 100 nM H 2 O 2 at early stage of differentiation (days 0-7), at a concentration expected from RacV12 activity within differentiating cells (Price et al., 2002) , to the embryoid bodies also severely impaired cardiac differentiation of ES cells, as shown by the lack of both transactivation of the MEF2C-dependent α-actin promoter and beating activity of embryoid bodies. On the other hand, the ROS scavenger, catalase added to the culture medium of embryoid bodies rescued MEF2C expression, myofibrillogenis and in turn beating activity of RacV12 embryoid bodies.
Together, these findings demonstrate the crucial deleterious role of Rac-induced ROS generation in early stages of cardiac cell differentiation.
Limitations of our cell model include the non-cell type-or time-restricted expression of RacV12, since the mutant was driven by an ubiquitous promoter leading to a strong overexpression (inset Fig 5) of a GTPase switched in constitutively activated and non-regulated conformation. Besides MEF2C downregulation, the cardiac phenotype of RacV12 embryoid bodies may be aggravated by ROS generation in any cell type which differentiated within embryoid bodies. Rac-generated ROS may induce a loss of cadherin-mediated cell-cell connection (van Wetering et al., 2002) , a process required for early cardiac development (Linask et al., 1997) .
Therefore, to provide more insight into the role of Rac in cardiac differentiation, we used the ventricular myosin light chain 2 promoter to specifically drive expression of GTPase mutants in ES-derived ventricular cells (Meyer et al., 2000) . Under such cardiac-and time-restricted expression, RacV12 significantly improved or accelerated the process of cardiac differentiation, as visualized by the extent of beating areas within EBs as soon as the MLC2v promoter was turned on at day 7 (Meyer et al., 2000) (Figure 9 ). A similar effect was observed with the fast cycling mutant RacF28, a more physiological way to increase Rac activity that can still be endogenously regulated. Furthermore, such an extensive beating area within the mesoderm of MLC2RacV12 EBs is similar to the one obtained in TGFβ−treated ES-derived cardiomyocytes (Behfar et al., 2002) , as expected from activation of Rac by the growth factor (Atfi et al., 1997) . In contrast, the dominant negative mutant RacN17 prevented cardiac myofibrillogenesis. Thus when expressed only in ventricular cells E02-09-0562 R1 17 and at a stage of differentiation when cardiac transcription factors has already reached maximal level of expression (Meyer et al., 2000) , Rac GTPase activity turns out to be required for terminal differentiation of cardiac precursors.
Two explanations are suggested to account for the great propensity of MLC2RacV12 ES cells to differentiate into contractile cardiomyocytes. First, Rac improves myofibrillogenesis of cardioblasts, as shown by a complete incorporation of
MLC2vGFP into sarcomeric units of ES-derived cardiomyocytes expressing RacV12
and an inhibition of the process in cells early or lately expressing RacN17. This effect is likely to depend on lamellipodia generated at the membrane by Rac. These actin structures serve as a niche for the setting of the first contractile proteins within the zbodies (Sanger et al., 2000) . Second, Rac prolongs proliferation of cardioblasts, as
shown by both Ki67 and BrdU staining (Fig 9) . This result is in line with the cardiac phenotype of RhoGDI-overexpressing mice (Wei et al., 2002) and with the expected effect of Rac on cyclin D1 (Coleman and Marshall, 2001) , E2F stimulation and pRb hyperphosphorylation (Gjoerup et al., 1998) .
Rac delays cardiac differentiation by repressing expression of a major cardiac transcription factor, MEF2C. At very early stages of differentiation and during gastrulation, the GTPase may thus be critical to facilitate proliferation and migration of cells, including muscle precursors (Knight et al., 2000) (Settleman, 1999; Settleman, 2000; Settleman, 2001; Sugihara et al., 1998) , while preventing cell differentiation of one of the earliest cell types developing in the embryo, namely, the cardioblast. This could be mediated partially by ROS and NFκB pathways (Babior, 1999; Joneson and Bar-Sagi, 1998; Joyce et al., 1999) . Rac-induced ROS may also be critical for the physiological apoptotic process that occurs during early stages of embryogenesis (Pampfer, 2000; Poelmann et al., 2000) . At later stages, Rac activated by cardiogenic factors such as TGFβ (Atfi et al., 1997) (Mucsi et al., 1996) RacN17 prevents full sarcomerogenesis. The graph on the right represents mean ±
